Evidence map›Paper›PMID 24386094›Full record

ArticlePloS one2013

FACS-based isolation, propagation and characterization of mouse embryonic cardiomyocytes based on VCAM-1 surface marker expression.

Annica Pontén, Stuart Walsh, Daniela Malan, Xiaojie Xian, Susanne Schéele, Laura Tarnawski, Bernd K Fleischmann, Stefan Jovinge

Abstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Annica PonténLund Strategic Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden.
Stuart WalshLund Strategic Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden.
Daniela MalanInstitute of Physiology I, Life & Brain Center, University of Bonn, Bonn, Germany.
Xiaojie XianLund Strategic Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden.
Susanne SchéeleLund Strategic Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden.
Laura TarnawskiLund Strategic Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden.
Bernd K FleischmannInstitute of Physiology I, Life & Brain Center, University of Bonn, Bonn, Germany.
Stefan JovingeLund Strategic Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden ; Department of Cardiology Scania University Hospital, Lund, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purification of cardiomyocytes from the embryonic mouse heart, embryonic stem (ES) or induced pluripotent stem cells (iPS) is a challenging task and will require specific isolation procedures. Lately the significance of surface markers for the isolation of cardiac cell populations with fluorescence activated cell sorting (FACS) has been acknowledged, and the hunt for cardiac specific markers has intensified. As cardiomyocytes have traditionally been characterized by their expression of specific transcription factors and structural proteins, and not by specific surface markers, this constitutes a significant bottleneck. Lately, Flk-1, c-kit and the cellular prion protein have been reported to specify cardiac progenitors, however, no surface markers have so far been reported to specify a committed cardiomyocyte. Herein show for the first time, that embryonic cardiomyocytes can be isolated with 98% purity, based on their expression of vascular cell adhesion molecule-1 (VCAM-1). The FACS-isolated cells express phenotypic markers for embryonic committed cardiomyocytes but not cardiac progenitors. An important aspect of FACS is to provide viable cells with retention of functionality. We show that VCAM-1 positive cardiomyocytes can be isolated with 95% viability suitable for in vitro culture, functional assays or expression analysis. In patch-clamp experiments we provide evidence of functionally intact cardiomyocytes of both atrial and ventricular subtypes. This work establishes that cardiomyocytes can be isolated with a high degree of purity and viability through FACS, based on specific surface marker expression as has been done in the hematopoietic field for decades. Our FACS protocol represents a significant advance in which purified populations of cardiomyocytes may be isolated and utilized for downstream applications, such as purification of ES-cell derived cardiomyocytes.

Indexed as

AnimalsBiomarkersCell Culture TechniquesCell ProliferationCells, CulturedEmbryo, MammalianFlow CytometryMiceMice, Inbred C57BLMyocardiumMyocytes, CardiacVascular Cell Adhesion Molecule-1BiomarkersVascular Cell Adhesion Molecule-1

Identifiers

PMID24386094
PMCPMC3875414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.